Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Lifevantage (LFVN) EBITDA (2016 - 2025)

Lifevantage's EBITDA history spans 16 years, with the latest figure at $17000.0 for Q4 2025.

  • For Q4 2025, EBITDA fell 99.09% year-over-year to $17000.0; the TTM value through Dec 2025 reached $8.1 million, up 19.68%, while the annual FY2025 figure was $10.5 million, 342.74% up from the prior year.
  • EBITDA reached $17000.0 in Q4 2025 per LFVN's latest filing, down from $2.0 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $4.9 million in Q2 2021 to a low of -$2.0 million in Q2 2022.
  • Average EBITDA over 5 years is $1.3 million, with a median of $1.1 million recorded in 2024.
  • Peak YoY movement for EBITDA: crashed 318.0% in 2022, then soared 1068.91% in 2024.
  • A 5-year view of EBITDA shows it stood at -$100000.0 in 2021, then plummeted by 318.0% to -$418000.0 in 2022, then skyrocketed by 53.83% to -$193000.0 in 2023, then skyrocketed by 1068.91% to $1.9 million in 2024, then plummeted by 99.09% to $17000.0 in 2025.
  • Per Business Quant, the three most recent readings for LFVN's EBITDA are $17000.0 (Q4 2025), $2.0 million (Q3 2025), and $2.3 million (Q2 2025).